Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Dieter Flesch‐Janys, Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Ann Smeets(German Cancer Research Center), Volker Arndt(German Cancer Research Center), Marjanka K. Schmidt(University of Cambridge), Hiltrud Brauch(German Cancer Research Center), Frederik Marmé(Heidelberg University), Ellen L. Goode(Mayo Clinic in Arizona), Natalia Bogdanova(Medizinische Hochschule Hannover), Peter A. Fasching(Universitätsklinikum Erlangen), Thilo Dörk(Hannover Re (Germany)), Thérèse Truong(Université Paris-Sud), Annegien Broeks, Joe Dennis(University of Cambridge), Laurien Van Dyck(Universität Hamburg), Pascal Guénel(Inserm), Alison M. Dunning(University of Cambridge), Anna González‐Neira(Spanish National Cancer Research Centre), Ian Tomlinson(University of Oxford), Douglas F. Easton(University of Cambridge), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Heli Nevanlinna(University of Helsinki), Susan L. Neuhausen(City of Hope), Elinor J. Sawyer(King's College London), Ute Hamann(German Cancer Research Center), Rainer Fagerholm(358 (Finland)), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Anja Rudolph(Institut für Qualität im Management (Germany)), Jaana M. Hartikainen(University of Eastern Finland), Børge G. Nordestgaard(Gentofte Hospital), Melissa C. Southey(The University of Melbourne), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Barbara Burwinkel(German Cancer Research Center), John L. Hopper(The University of Melbourne), Primitiva Menéndez(City of Hope), Sune F. Nielsen(Herlev Hospital), Rita K. Schmutzler(The University of Melbourne), Julian Peto(University of Helsinki), Henrik Flyger(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Lothar Haeberle(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jieping Lei(Chinese Academy of Medical Sciences & Peking Union Medical College), Alfons Meindl(Helmholtz Zentrum München)
Cited by 10
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k